UVA Cancer Center, an NCI Comprehensive Cancer Center | Strategic Alliance Partners

Latest from UVA Cancer Center, an NCI Comprehensive Cancer Center


Dr. Gentzler on the Role of Chemotherapy in Metastatic NSCLC

August 21, 2018

Ryan D. Gentzler, MD, assistant professor, Division of Hematology/Oncology, University of Virginia Health System, discusses the role of chemotherapy in patients with metastatic non–small cell lung cancer (NSCLC).

Most Patients in Need of HCT Can Now Get Transplants

December 11, 2017

Due to great progress in alternative donor transplants, almost all transplant-eligible patients, up to age 75 years, in 2017 will be able to find a suitable donor and proceed to transplant, a major advance over the past 10 years.

Dr. Dreicer on Abiraterone and Enzalutamide in Prostate Cancer

March 24, 2017

Robert Dreicer, MD, associate director for Clinical Research and deputy director of the University of Virginia Cancer Center, discusses abiraterone acetate (Zytiga) and enzalutamide (Xtandi) in metastatic castration-resistant prostate cancer (mCRPC).

Enhanced Recovery Program Improves Outcomes After Colorectal Cancer Surgery

February 03, 2017

The adoption of enhanced recovery after surgery protocols can improve not only the outcomes of patients after a procedure but can also reduce hospital costs, as has been seen in an ERAS program in colorectal cancer at the University of Virginia Health System.

It's Time to Take Action on Quality Improvement Measures

October 21, 2016

In 2014, under the leadership of UVA Executive Vice President Richard P. Shannon, MD, the Be Safe initiative was developed to deliver the highest-quality of advanced healthcare to patients, and emphasizes 3 main areas.

Studies Challenge Common Treatment Strategies in Prostate Cancer

May 08, 2014

Two recent studies have raised questions about current trends in prostate cancer (PC) treatment, one supporting the employment of a little-used strategy-direct treatment of the primary tumor in men who have metastatic PC at diagnosis